Loading…
Kingdom Harvest was cited for selling unapproved new drugs in violation of the Federal Food, Drug, and Cosmetic Act, specifically cannabidiol (CBD) and Delta-8 tetrahydrocannabinol (THC) products marketed for human and animal use without FDA approval. The company's products—including sublingual oils, vape cartridges, gummies, creams, and food items infused with CBD or Delta-8—were found to be misbranded and sold without required drug approvals through their website and social media platforms (Facebook and Instagram). The FDA identified violations under sections 505(a) and 301(d) of the FD&C Act for unapproved new drugs and section 502(f)(1) for misbranding, based on a review of the company's marketing claims conducted between October 2021 and April 2022.